CIK 0001863127
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Tyra Biosciences, Inc.
Sign in to watch- Ticker
- TYRA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 831476348
- Phone
- +1 619-728-4760
- Business address
- 2656 STATE STREET, CARLSBAD, CA, 92008
- Open-market buys, last 90 days
- $20,000
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$20,000. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-06-29 | Bensen Daniel Chief Operating Officer | Option exercise 10b5-1 | +17,281 | $0.61 | $11K | 545,262 |
| 2023-06-29 | Bensen Daniel Chief Operating Officer | Sale 10b5-1 | −17,281 | $16.49 | $285K | 527,981 |
| 2023-06-29 | Bensen Daniel Chief Operating Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −17,281 | 164,997 | ||
| 2023-06-28 | Bensen Daniel Chief Operating Officer | Option exercise 10b5-1 | +13,524 | $0.61 | $8K | 541,505 |
| 2023-06-28 | Bensen Daniel Chief Operating Officer | Sale 10b5-1 | −13,524 | $16.91 | $229K | 527,981 |
| 2023-06-28 | Bensen Daniel Chief Operating Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −13,524 | 182,278 | ||
| 2023-06-27 | Bensen Daniel Chief Operating Officer | Option exercise 10b5-1 | +16,028 | $0.61 | $10K | 544,009 |
| 2023-06-27 | Bensen Daniel Chief Operating Officer | Sale 10b5-1 | −7,893 | $16.73 | $132K | 536,116 |
| 2023-06-27 | Bensen Daniel Chief Operating Officer | Sale 10b5-1 | −8,135 | $17.09 | $139K | 527,981 |
| 2023-06-27 | Bensen Daniel Chief Operating Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −16,028 | 195,802 | ||
| 2023-06-26 | Bensen Daniel Chief Operating Officer | Option exercise 10b5-1 | +17,232 | $0.61 | $11K | 545,213 |
| 2023-06-26 | Bensen Daniel Chief Operating Officer | Sale 10b5-1 | −10,862 | $16.49 | $179K | 534,351 |
| 2023-06-26 | Bensen Daniel Chief Operating Officer | Sale 10b5-1 | −6,370 | $17.24 | $110K | 527,981 |
| 2023-06-26 | Bensen Daniel Chief Operating Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −17,232 | 211,830 | ||
| 2023-06-23 | Harris Todd Chief Executive Officer | Sale 10b5-1 | −14,231 | $16.78 | $239K | 1,607,757 |
| 2023-06-23 | Harris Todd Chief Executive Officer | Sale 10b5-1 | −6,481 | $17.51 | $113K | 1,601,276 |
| 2023-06-22 | Harris Todd Chief Executive Officer | Sale 10b5-1 | −2,978 | $16.98 | $51K | 1,622,488 |
| 2023-06-22 | Harris Todd Chief Executive Officer | Sale 10b5-1 | −500 | $17.39 | $9K | 1,621,988 |
| 2023-06-21 | Harris Todd Chief Executive Officer | Sale 10b5-1 | −4,629 | $16.12 | $75K | 1,640,593 |
| 2023-06-21 | Harris Todd Chief Executive Officer | Sale 10b5-1 | −14,027 | $17.71 | $248K | 1,626,566 |
Page 11 of 21 · 417 trades